Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05976425Terminated

ModPG3 Neo-Infant ISO 81060-2:2018

Role: lead

NCT05654714Terminated

ModPG3 Adult/Ped ISO 81060-2:2018 Study Protocol

Role: lead

NCT03860727Completed

Comparison of Ophthalmoscopy Findings Using PanOptic vs PanOptic + iExaminer

Role: collaborator

NCT02823600Not ApplicableCompleted

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

Role: collaborator

NCT03479021Unknown

SPOT Vision Screening

Role: collaborator

NCT02475577Not ApplicableUnknown

Determine Return on Investment in Heart Failure Remote Monitoring Program

Role: collaborator

NCT00682526Completed

Pre-Hospital Wireless Transmission of Electrocardiograms to a Cardiologist Via a Hand-Held Device

Role: lead

All 7 trials loaded